Reported 3 months ago
Moderna's shares have plummeted after the company revised its sales forecast downward due to decreased demand for COVID and RSV vaccines. This shift comes against a backdrop of uncertainty surrounding the incoming Trump administration and its potential impact on pharmaceutical regulations, particularly with the nomination of Robert F. Kennedy Jr., known for his vocal anti-vaccine stance.
Source: YAHOO